A randomized, open-label, 2 way crossover study to assess the reciprocal effects of co-administration of rosuvastatin 40 mg and ezetimibe 10 mg on the steady state pharmacokinetics of each drug

Trial Profile

A randomized, open-label, 2 way crossover study to assess the reciprocal effects of co-administration of rosuvastatin 40 mg and ezetimibe 10 mg on the steady state pharmacokinetics of each drug

Not stated
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 28 Mar 2006

At a glance

  • Drugs Ezetimibe (Primary) ; Rosuvastatin (Primary)
  • Indications Lipid metabolism disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top